A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA

被引：0
|
作者：
Reardon, David A. [1 ]
Vredenburgh, James J. [1 ]
Desjardins, Annick [1 ]
Janney, Dorothea E. [1 ]
Peters, Katherine [1 ]
Sampson, John [1 ]
Gururangan, Sri [1 ]
Friedman, Henry S. [1 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Katherine B. Peters
    Eric S. Lipp
    Elizabeth Miller
    James E. Herndon
    Frances McSherry
    Annick Desjardins
    David A. Reardon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2018, 137 : 349 - 356
  • [2] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Peters, Katherine B.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Desjardins, Annick
    Reardon, David A.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 349 - 356
  • [3] Bevacizumab versus bevacizumab plus vorinostat in adults with recurrent malignant glioma: Results of a phase I part of a phase I/II trial
    Wu, Jing
    Groves, Morris D.
    Gilbert, Mark R.
    Hess, Kenneth R.
    Loch, Carolyn Sue
    Ictech, Sandra
    De Groot, John Frederick
    Conrad, Charles A.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Phase I/II study of BIBW 2992 with or without daily temozolomide in the treatment of patients with recurrent malignant glioma
    Reardon, D. A.
    Fu, Y.
    Thurm, H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS
    Desjardins, Annick
    Vredenburgh, James J.
    Gururangan, Sridharan
    Peters, Katherine B.
    Friedman, Allan H.
    Friedman, Henry
    Reardon, David A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 633 - 633
  • [7] BEVACIZUMAB PLUS TEMOZOLOMIDE FOR RECURRENT MALIGNANT GLIOMA: UPDATE
    Badruddoja, Michael A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 631 - 631
  • [8] Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
    D A Reardon
    A Desjardins
    J J Vredenburgh
    S Gururangan
    J H Sampson
    S Sathornsumetee
    R E McLendon
    J E Herndon
    J E Marcello
    J Norfleet
    A H Friedman
    D D Bigner
    H S Friedman
    British Journal of Cancer, 2009, 101 : 1986 - 1994
  • [9] Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
    Reardon, D. A.
    Desjardins, A.
    Vredenburgh, J. J.
    Gururangan, S.
    Sampson, J. H.
    Sathornsumetee, S.
    McLendon, R. E.
    Herndon, J. E., II
    Marcello, J. E.
    Norfleet, J.
    Friedman, A. H.
    Bigner, D. D.
    Friedman, H. S.
    BRITISH JOURNAL OF CANCER, 2009, 101 (12) : 1986 - 1994
  • [10] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
12345